UPM-Kymmene Oyj (LON:0NV5)
London · Delayed Price · Currency is GBP · Price in EUR 24.19
+0.16 (0.65%)
At close: Aug 15, 2025
UPM-Kymmene Oyj Revenue
UPM-Kymmene Oyj had revenue of 2.40B EUR in the quarter ending June 30, 2025, a decrease of -5.73%. This brings the company's revenue in the last twelve months to 10.20B, down -0.99% year-over-year. In the year 2024, UPM-Kymmene Oyj had annual revenue of 10.34B, down -1.16%.
Revenue (ttm)
10.20B EUR
Revenue Growth
-0.99%
P/S Ratio
1.25
Revenue / Employee
644.41K EUR
Employees
15,827
Market Cap
10.97B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.34B | -121.00M | -1.16% |
| Dec 31, 2023 | 10.46B | -1.26B | -10.75% |
| Dec 31, 2022 | 11.72B | 1.91B | 19.42% |
| Dec 31, 2021 | 9.81B | 1.23B | 14.38% |
| Dec 31, 2020 | 8.58B | -1.66B | -16.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Shell | 198.54B |
| Unilever | 51.24B |
| British American Tobacco p.l.c. | 25.60B |
| Rolls-Royce Holdings | 19.54B |
| Rio Tinto Group | 39.22B |
| BP p.l.c. | 134.89B |